Powering precision medicine for the brain
Beacon’s EEG neurobiomarker platform is engineered to accelerate clinical trials and enable new treatments for patients with neurological and psychiatric disease.
Learn More
Biomarker Applications
Treatment EfficacyQuantitative assessment of treatment impact on EEG and sleep data ensure clinical endpoints are reached
PK/PD & Dose SelectionUnderstand PK/PD relationships with brain activity to identify doses with optimal efficacy and safety profiles
Population StratificationIdentify optimal patient populations to understand and select cohorts
Enabled by our end-to-end augmented EEG platform
Dreem Headband
State of the Art Machine Learning
World-Class Clinico-EEG Database
How We Create Impact
Translational ResearchAnalyze existing EEG for insights into mechanism, PK/PD and patient stratification to guide further development efforts
Clinical Trial OptimizationDemonstrate target engagement, guide dose selection, and deploy quantitative endpoints to improve probability of trial and regulatory success
Commercial DifferentiationEnhance understanding of treatment efficacy and guide label expansion for new therapeutic applications
Where We Can Help
WITH INDUSTRY LEADERS INCLUDING
Partnerships
We partner with biopharma companies, academic medical centers, and neurotechnology developers to improve the diagnosis and treatment of neurological and psychiatric diseases.